High expression of solute carrier family 2 facilitated glucose transporter member 3 (SLC2A3) is closely associated with poor prognosis of papillary thyroid cancer [21] and colorectal cancer [22]. This evidence concerns the gene SLC2A3 and thyroid gland papillary carcinoma.